ROZUMNYI, Viktor et al. Sustained disease control with aflibercept 8 mg: A turning point in the management of exudative retinal disease: Expert consenus. Ukrainian Journal of Ophthalmology , Odesa, Ukraine, n. 2, p. 71–76, 2026. DOI: 10.31288/Ukr.j.ophthalmol.202627176. Disponível em: https://ua.ozhurnal.com/index.php/files/article/view/712. Acesso em: 27 apr. 2026.